Virtual Meeting to be held on April 28-30 hosted by B. Riley.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRVI:
- Trevi Therapeutics management to meet with Cantor Fitzgerald
- Trevi Therapeutics’ Haduvio: A Promising Therapy for IPF and RCC with Anticipated CORAL Trial Results
- Trevi Therapeutics’ Earnings Call: Clinical Success Amid Financial Challenges
- Trevi Therapeutics Stock (TRVI) Surges Over 60% on Promising Trial Results and Q4 Financials
- Trevi Therapeutics price target raised to $20 from $11 at B. Riley